Back to Search Start Over

The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors

Authors :
Cheng, Hengmiao
Hoffman, Jacqui
Le, Phuong
Nair, Sajiv K.
Cripps, Stephan
Matthews, Jean
Smith, Christopher
Yang, Michele
Kupchinsky, Stan
Dress, Klaus
Edwards, Martin
Cole, Bridget
Walters, Evan
Loh, Christine
Ermolieff, Jacques
Fanjul, Andrea
Bhat, Ganesh B.
Herrera, Jocelyn
Pauly, Tom
Hosea, Natilie
Source :
Bioorganic & Medicinal Chemistry Letters. May2010, Vol. 20 Issue 9, p2897-2902. 6p.
Publication Year :
2010

Abstract

Abstract: The design and development of a series of highly selective pyrrolidine carboxamide 11β-HSD1 inhibitors are described. These compounds including PF-877423 demonstrated potent in vitro activity against both human and mouse 11β-HSD1 enzymes. In an in vivo assay, PF-877423 inhibited the conversion of cortisone to cortisol. Structure guided optimization effort yielded potent and stable 11β-HSD1 selective inhibitor 42. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
0960894X
Volume :
20
Issue :
9
Database :
Academic Search Index
Journal :
Bioorganic & Medicinal Chemistry Letters
Publication Type :
Academic Journal
Accession number :
49817550
Full Text :
https://doi.org/10.1016/j.bmcl.2010.03.032